Publication: SOLTI-1910: Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1/2, PALB2, RAD51C/D mutations or HRD by the RAD51 test: RADIOLA trial
| dc.conference.date | MAY 03-05, 2022 | |
| dc.conference.title | European-Society-for-Medical-Oncology (ESMO) Breast Cancer Congress | |
| dc.contributor.author | Balmana, J. | |
| dc.contributor.author | Pascual, T. | |
| dc.contributor.author | Llop-Guevara, A. | |
| dc.contributor.author | Tolosa, P. | |
| dc.contributor.author | Blancas Lopez-Barajas, I. | |
| dc.contributor.author | Perez Lopez, M. E. | |
| dc.contributor.author | Adamo, B. | |
| dc.contributor.author | Teruel-Garcia, I. | |
| dc.contributor.author | Ponce, J. | |
| dc.contributor.author | Gonzalez-Cordero, M. | |
| dc.contributor.author | Vinas Villaro, G. | |
| dc.contributor.author | Lema Roso, L. | |
| dc.contributor.author | Salvador Bofill, F. J. | |
| dc.contributor.author | Martinez, M. T. M. | |
| dc.contributor.author | Guerrero, A. N. E. | |
| dc.contributor.author | Prat, A. | |
| dc.contributor.author | Serra Elizalde, V. | |
| dc.contributor.authoraffiliation | [Balmana, J.] Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain | |
| dc.contributor.authoraffiliation | [Pascual, T.] Hosp Clin Barcelona, SOLTI Canc Res Grp, Clin Res Dept, Barcelona, Spain | |
| dc.contributor.authoraffiliation | [Llop-Guevara, A.] Vall dHebron Inst Oncol VHIO, Cellex Ctr, Barcelona, Spain | |
| dc.contributor.authoraffiliation | [Tolosa, P.] Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain | |
| dc.contributor.authoraffiliation | [Blancas Lopez-Barajas, I.] Hosp Clin San Cecilio, Oncol Dept, Granada, Spain | |
| dc.contributor.authoraffiliation | [Perez Lopez, M. E.] CHUAC Complexo Hosp Univ A Coruna, Oncol, La Coruna, Spain | |
| dc.contributor.authoraffiliation | [Adamo, B.] Hosp Clin Barcelona, Breast Canc Dept, Barcelona, Spain | |
| dc.contributor.authoraffiliation | [Teruel-Garcia, I.] Hosp Badalona Germans Trias & Pujol, ICO Inst Catala Oncol Badalona, Med Oncol, Badalona, Spain | |
| dc.contributor.authoraffiliation | [Ponce, J.] Hosp Gen Univ Alicante, Med Oncol Dept, Alicante, Spain | |
| dc.contributor.authoraffiliation | [Gonzalez-Cordero, M.] Hosp Univ Badajoz, Hosp Infanta Cristina, Med Oncol Dept, Badajoz, Spain | |
| dc.contributor.authoraffiliation | [Vinas Villaro, G.] Hosp Univ Josep Trueta, Catalan Inst Oncol ICO, Med Oncol, Girona, Spain | |
| dc.contributor.authoraffiliation | [Lema Roso, L.] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain | |
| dc.contributor.authoraffiliation | [Salvador Bofill, F. J.] Hosp Univ Virgen Valme, Med Oncol Dept, Seville, Spain | |
| dc.contributor.authoraffiliation | [Martinez, M. T. M.] Hosp Clin Univ Valencia, Oncol Dept, Valencia, Spain | |
| dc.contributor.authoraffiliation | [Guerrero, A. N. E.] SOLTI Canc Res Grp, Sci, Barcelona, Spain | |
| dc.contributor.authoraffiliation | [Prat, A.] Hosp Clin Barcelona, Med Oncol Dept, Barcelona, Spain | |
| dc.contributor.authoraffiliation | [Serra Elizalde, V.] Vall dHebron Inst Oncol VHIO Cellex Ctr, Expt Therapeut Grp Dept, Barcelona, Spain | |
| dc.date.accessioned | 2023-05-03T14:39:49Z | |
| dc.date.available | 2023-05-03T14:39:49Z | |
| dc.date.issued | 2022-05-05 | |
| dc.identifier.doi | 10.1016/j.annonc.2022.03.072 | |
| dc.identifier.essn | 1569-8041 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753422004513/pdf | |
| dc.identifier.uri | http://hdl.handle.net/10668/21898 | |
| dc.identifier.wosID | 792494100060 | |
| dc.issue.number | 3 | |
| dc.journal.title | Annals of oncology | |
| dc.journal.titleabbreviation | Ann. oncol. | |
| dc.language.iso | en | |
| dc.organization | Hospital Universitario San Cecilio | |
| dc.organization | Hospital Universitario San Cecilio | |
| dc.organization | Área de Gestión Sanitaria Sur de Sevilla | |
| dc.organization | Área de Gestión Sanitaria Sur de Sevilla | |
| dc.organization | AGS - Sur de Sevilla | |
| dc.organization | AGS - Sur de Sevilla | |
| dc.page.number | S146-S147 | |
| dc.publisher | Elsevier | |
| dc.rights.accessRights | open access | |
| dc.title | SOLTI-1910: Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1/2, PALB2, RAD51C/D mutations or HRD by the RAD51 test: RADIOLA trial | |
| dc.type | conference output | |
| dc.type.hasVersion | VoR | |
| dc.volume.number | 33 | |
| dc.wostype | Meeting Abstract | |
| dspace.entity.type | Publication |